KCT0006358招募中未知
Comparison of oral chloral hydrate and combination of intranasal dexmedetomidine and ketamine for procedural sedation in children: a randomized controlled trial
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 136
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- o Limit 至 6(Year)（—）
- 性别
- All
入选标准
- •? Pediatric patients who need procedural sedation, Age < 7 years
- •? ASA (American Society of Anesthesiologists) physical status 1-3
- •? Parent's approval of written informed consent
排除标准
- •?ASA (American Society of Anesthesiologists) physical status 4-5
- •?History of hypersensitivity to Dexmedetomidine, Ketamine, or Chloral hydrate
- •?Recent administration of Alpha 2 adrenergic receptor agonist or antagonist
- •?Swallowing difficulty (oral administration is not possible)
- •?Excessive rhinorrhea (intranasal administration is not possible)
- •?Unstable vital sign (heart rate, blood pressure) or significant arrhythmia
- •?Recent (< 2 weeks) history of pneumonia, or upper respiratory infection
- •?Investigator's decision
- •?General contraindication of Dexmedetomidine, Ketamine, or Chloral hydrate
- •Do not administer to patients with hypersensitivity or past history hypersensitivity to this drug / Use with caution in patients with 1) cardiovascular disease, 2) impaired heart function, 3) reduced circulatory blood flow, 4) hepatic impairment, 5) renal impairment, 6) old age, 7) patients on hemodialysis, and 8) dependency or past history dependency to medication.
- •Do not administer to the following patients with: 1) hypersensitivity or past history hypersensitivity to this drug, 2) cerebrovascular disease, hypertension (SBP > 160mmHg, DBP > 100mmHg), Increased intracranial pressure, or severe heart failure, 3) history of seizure, 4) outpatient, 5) eclampsia or preeclampsia, 6) uncontrolled hyperthyroidism, 7) glaucoma or increased intraocular pressure, 8) severe heart failure, 9) surgery in the pharynx, larynx, or trachea without adequate neuromuscular blockade. / Use with caution in patients with 1) alcoholics, 2) using beta-blockers, 3) recent history of unstable angina or myocardial infarction 4) respiratory distress, 5) ocular injury such as penetrating trauma, 6) upper respiratory infection; can increase the risk of respiratory complication such as laryngospasm, and 7) increased cerebrospinal fluid pressure before the induction of anesthesia.
- •Do not administer to the following patients with: 1) Hepatic or renal impairment, 2) severe heart disease, 3) gastritis 4) hypersensitivity or past history hypersensitivity to this drug, 5)acute intermittent porphyria, and 6) using coumarin-based anticoagulants / Use with caution in patients with 1) fragile 2) respiratory depression, 3) old age and 4) this drug contains yellow 5 (Sunset Yellow FCF, Sunset Yellow FCF), so be careful in patients with hypersensitivity or past history hypersensitivity to this sunset yellow FCF.
研究者
相似试验
招募中
不适用
Comparison of oral chloral hydrate and combination of intranasal dexmedetomidine and ketamine for rescue after failed pediatric procedural sedation: a randomized controlled trialKCT0006360Seoul National University Hospital70
已完成
不适用
Comparison of effectiveness of chloral hydrate and promethazine in electroencephalographyepilepsy.Epilepsy and paroxysmal disordersG40, G47IRCT138903032639N2Deputy of research -Shaheed Sadoughi University of Medical Sciences and Health Services60
已完成
不适用
oral chloral hydrate and intranasal midazolam in sedation induction for CT scaother disorders of the nervous system.Other disorders of the nervous systemG90-G99IRCT201107082639N4Deputy of research -Shaheed Sadoughi University of Medical Sciences ,Yazd,Iran60
招募中
3 期
Comparison between the effect of oral chloral hydrate and intranasal dexmedetomidine on pediatric sedation for EEGSedation.IRCT20180520039739N3Esfahan University of Medical Sciences60
招募中
3 期
Comparison between the effect of oral chloral hydrate and intranasal Fentanyl on sedatiomean arterial pressure,o2 saturation,heart rate, respiratory rate ,degree of sedation by RAMSEY scale.IRCT20191205045618N1Esfahan University of Medical Sciences62